Clinical Trial Update: Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss [Phase 3]

View source ↗

Summary

Extension study of a Phase 3 trial evaluating GZR18 Injection for weight loss is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Overweight or Obesity | Phase 3 | Status: RECRUITING